Samantha Pearce is the Executive Vice President and Chief Commercial Officer (CCO) at Jazz Pharmaceuticals PLC, a leading biopharmaceutical company dedicated to developing life-changing medicines for people with serious diseases. In her role, Pearce oversees the company's global commercial strategy, driving the growth and expansion of Jazz Pharmaceuticals' portfolio of innovative therapies. Her leadership is instrumental in ensuring that the company's products reach the patients who need them most, while also maximizing value for shareholders. Before joining Jazz Pharmaceuticals, Pearce built an impressive career in the pharmaceutical industry, holding key leadership positions at several major companies. She previously served as Senior Vice President and General Manager at Allergan, where she led the company's U.S. eye care business and played a pivotal role in the successful launch of several new products. Pearce also spent over a decade at Novartis, where she held various roles of increasing responsibility, including leading the company's U.S. oncology business. Throughout her career, she has demonstrated a strong track record of driving commercial success, fostering high-performing teams, and navigating complex market dynamics. Pearce's contributions to Jazz Pharmaceuticals have been significant since joining the company. Under her leadership, the company has successfully launched several new products, expanded its global footprint, and strengthened its position as a leader in the biopharmaceutical industry. Her strategic vision and deep understanding of the healthcare landscape have been crucial in guiding Jazz Pharmaceuticals through a period of rapid growth and transformation. Pearce's dedication to improving patient outcomes, combined with her proven commercial expertise, make her an invaluable asset to the company and a respected leader in the industry.